Neuropharmacology 2016 - 26th Neuropharmacology Conference: Ionotropic Glutamate Receptors
Date2016-11-10 - 2016-11-11
Deadline2016-05-13
VenueParadise Point, San Diego, CA, USA - United States
Keywords
Topics/Call fo Papers
The 26th Neuropharmacology Conference will be held in San Diego, California, USA from 10 -11 November 2016, under the theme: Ionotropic Glutamate Receptors.
Glutamate is the major excitatory neurotransmitter in the central nervous system where its actions are mediated largely via three classes of ionotropic glutamate receptors (iGluRs) - AMPA, NMDA and kainate. These receptors are involved in numerous physiological functions and are the targets of drugs used in the treatment of Alzheimer’s disease, epilepsy and pain.
The 26th Neuropharmacology Conference will provide an overview of the field with a particular focus on recent advances in iGluR structure, the design of new ligands and the role of iGluRs in synaptic plasticity.
There will be a major emphasis on how the study of iGluRs is leading to considerable insights into the aetiology of major disorders, such as depression, schizophrenia and autism, and will evaluate the potential of targeting iGluRs for new therapies.
Abstract Submission Deadline: 13 May 2016
Oral and paper abstracts are now invited on the following topics. They should be submitted using the online abstract submission system.
Conference Topics:
Ionotropic glutamate receptors
Synaptic plasticity and memory
Structure/Function
Homeostatic plasticity
Physiology and signaling
Neurological and Psychiatric Disorders
Novel therapeutic approaches and potential applications
Glutamate is the major excitatory neurotransmitter in the central nervous system where its actions are mediated largely via three classes of ionotropic glutamate receptors (iGluRs) - AMPA, NMDA and kainate. These receptors are involved in numerous physiological functions and are the targets of drugs used in the treatment of Alzheimer’s disease, epilepsy and pain.
The 26th Neuropharmacology Conference will provide an overview of the field with a particular focus on recent advances in iGluR structure, the design of new ligands and the role of iGluRs in synaptic plasticity.
There will be a major emphasis on how the study of iGluRs is leading to considerable insights into the aetiology of major disorders, such as depression, schizophrenia and autism, and will evaluate the potential of targeting iGluRs for new therapies.
Abstract Submission Deadline: 13 May 2016
Oral and paper abstracts are now invited on the following topics. They should be submitted using the online abstract submission system.
Conference Topics:
Ionotropic glutamate receptors
Synaptic plasticity and memory
Structure/Function
Homeostatic plasticity
Physiology and signaling
Neurological and Psychiatric Disorders
Novel therapeutic approaches and potential applications
Other CFPs
Last modified: 2016-03-15 23:12:14